BASSINDALE, Thomas (2011). Benzylpiperazine: the New Zealand legal perspective. Drug Testing and Analysis, 3 (7-8), 428-429.Full text not available from this repository.
In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed.
|Research Institute, Centre or Group:||Biomedical Research Centre|
|Depositing User:||Rebecca Jones|
|Date Deposited:||08 Feb 2012 17:01|
|Last Modified:||08 Feb 2012 17:01|
Actions (login required)
Downloads per month over past year